Weight-loss giant Novo Nordisk's shares rose over 5% on Friday ​to a high last touched in October, ‌driven by "encouraging" ...

Britain's health regulator approved a maximum weekly dose of up to 7.2 milligrams of Novo Nordisk's blockbuster weight-loss ...

The U.K.’s health regulator approved a higher dose of Novo Nordisk’s Wegovy weight-loss drug applicable to patients with a ...

The early data is a boost to the Danish drugmaker's hopes of winning back more market share from Eli Lilly this year in the ...

In a landmark move for UK patients with obesity, the Medicines and Healthcare products Regulatory Agency (MHRA) has approved ...

Shares in Denmark's global healthcare company, Novo Nordisk jumped sharply on Friday after the U.K.'s regulator signed off on ...

Semaglutide, sold under the brand names Wegovy and Ozempic, has helped Novo establish a foothold in the market for ...

Doctors break down the difference between Wegovy’s GLP-1 injections and pills, plus how to decide which is right for you.

The medication, available at a lower cost, is an alternative to injections and increases accessibility for patients, some ...

Does the new Wegovy pill work as well as Wegovy injections for weight loss? How else does it compare? Learn what the experts ...

You know how true the above statement is, especially if you’ve struggled with your weight most of your life. What you might ...

The first data has emerged on the uptake of Novo Nordisk's new oral version of GLP-1 agonist weight-loss therapy Wegovy, with ...